Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

2018 UK national guideline for the management of infection with Neisseria gonorrhoeae.

Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M.

Int J STD AIDS. 2020 Jan;31(1):4-15. doi: 10.1177/0956462419886775. No abstract available.

PMID:
31870237
2.

Amendment to the UK guidelines on the management of syphilis 2015: Management of syphilis in pregnant women.

Kingston M, Fifer H, French P, Wilson J, Tipple C.

Int J STD AIDS. 2019 Nov;30(13):1344-1345. doi: 10.1177/0956462419862723. No abstract available.

PMID:
31775588
3.

Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.

Cole MJ, Tan W, Fifer H, Brittain C, Duley L, Hepburn T, Lawrence T, Montgomery AA, Sprange K, Thandi S, Churchward C, Tripodo F, Woodford N, Ross JDC.

J Antimicrob Chemother. 2020 Feb 1;75(2):449-457. doi: 10.1093/jac/dkz436.

PMID:
31670808
4.

Prevalence of new variants of Chlamydia trachomatis escaping detection by the Aptima Combo 2 assay, England, June to August 2019.

Roberts DJ, Davis GS, Cole MJ, Naik D, Maru H, Woodford N, Muir P, Horner P, Simms I, Thickett G, Crook P, Foster K, Andrews N, Saunders J, Fifer H, Folkard K, Gill ON, On Behalf Of The Incident Management Team.

Euro Surveill. 2019 Sep;24(38). doi: 10.2807/1560-7917.ES.2019.24.38.1900557.

5.

Mycoplasma genitalium: A Review.

Gnanadurai R, Fifer H.

Microbiology. 2019 Jul 22. doi: 10.1099/mic.0.000830. [Epub ahead of print]

PMID:
31329090
6.

British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018).

Soni S, Horner P, Rayment M, Pinto-Sander N, Naous N, Parkhouse A, Bancroft D, Patterson C, Fifer H.

Int J STD AIDS. 2019 Sep;30(10):938-950. doi: 10.1177/0956462419825948. Epub 2019 Jul 7. No abstract available. Erratum in: Int J STD AIDS. 2019 Aug 12;:956462419870463.

PMID:
31280688
7.

Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae.

Pitt R, Sadouki Z, Town K, Fifer H, Mohammed H, Hughes G, Woodford N, Cole MJ.

J Antimicrob Chemother. 2019 Jul 1;74(7):2115-2116. doi: 10.1093/jac/dkz130. No abstract available.

PMID:
31225605
8.
9.

Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018.

Eyre DW, Town K, Street T, Barker L, Sanderson N, Cole MJ, Mohammed H, Pitt R, Gobin M, Irish C, Gardiner D, Sedgwick J, Beck C, Saunders J, Turbitt D, Cook C, Phin N, Nathan B, Horner P, Fifer H.

Euro Surveill. 2019 Mar;24(10). doi: 10.2807/1560-7917.ES.2019.24.10.1900147.

10.

Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018.

Jennison AV, Whiley D, Lahra MM, Graham RM, Cole MJ, Hughes G, Fifer H, Andersson M, Edwards A, Eyre D.

Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1900118.

11.

Treatment for pharyngeal gonorrhoea under threat.

Regan DG, Hui BB, Wood JG, Fifer H, Lahra MM, Whiley DM.

Lancet Infect Dis. 2018 Nov;18(11):1175-1177. doi: 10.1016/S1473-3099(18)30610-8. Epub 2018 Oct 24. No abstract available.

PMID:
30507396
12.

Point-of-care tests for chlamydia and gonorrhoea in Indigenous communities.

Hughes G, Fifer H.

Lancet Infect Dis. 2018 Oct;18(10):1054-1055. doi: 10.1016/S1473-3099(18)30486-9. No abstract available.

PMID:
30303094
13.

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.

Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, Barker L, Morgan M, Newnham R, Golparian D, Unemo M, Crook DW, Peto TE, Hughes G, Cole MJ, Fifer H, Edwards A, Andersson MI.

Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1800323.

14.

Persistence of an outbreak of gonorrhoea with high-level resistance to azithromycin in England, November 2014‒May 2018.

Smolarchuk C, Wensley A, Padfield S, Fifer H, Lee A, Hughes G.

Euro Surveill. 2018 Jun;23(23). doi: 10.2807/1560-7917.ES.2018.23.23.1800287.

15.

Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study.

Fifer H, Cole M, Hughes G, Padfield S, Smolarchuk C, Woodford N, Wensley A, Mustafa N, Schaefer U, Myers R, Templeton K, Shepherd J, Underwood A.

Lancet Infect Dis. 2018 May;18(5):573-581. doi: 10.1016/S1473-3099(18)30122-1. Epub 2018 Mar 6.

PMID:
29523496
16.

Is previous azithromycin treatment associated with azithromycin resistance in Neisseria gonorrhoeae? A cross-sectional study using national surveillance data in England.

Clifton S, Town K, Furegato M, Cole M, Mohammed H, Woodhall SC, Kevin Dunbar J, Fifer H, Hughes G.

Sex Transm Infect. 2018 Sep;94(6):421-426. doi: 10.1136/sextrans-2017-053461. Epub 2018 Mar 6.

PMID:
29511067
17.

Highlighting the clinical need for diagnosing Mycoplasma genitalium infection.

Ison CA, Fifer H, Gwynn S, Horner P, Muir P, Nicholls J, Radcliffe K, Ross J, Taylor-Robinson D, White J.

Int J STD AIDS. 2018 Jun;29(7):680-686. doi: 10.1177/0956462417753527. Epub 2018 Feb 10.

PMID:
29431025
18.

Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys.

Clifton S, Bolt H, Mohammed H, Town K, Furegato M, Cole M, Campbell O, Fifer H, Hughes G.

J Antimicrob Chemother. 2018 Apr 1;73(4):923-932. doi: 10.1093/jac/dkx520.

19.

Factors associated with four atypical cases of congenital syphilis in England, 2016 to 2017: an ecological analysis.

Furegato M, Fifer H, Mohammed H, Simms I, Vanta P, Webb S, Foster K, Kingston M, Charlett A, Vishram B, Reynolds C, Gill N, Hughes G.

Euro Surveill. 2017 Dec;22(49). doi: 10.2807/1560-7917.ES.2017.22.49.17-00750.

20.

Evaluation of the Mycoplasma genitalium Resistance Plus kit for the detection of M. genitalium and mutations associated with macrolide resistance.

Pitt R, Cole MJ, Fifer H, Woodford N.

Sex Transm Infect. 2018 Dec;94(8):565-567. doi: 10.1136/sextrans-2017-053366. Epub 2017 Nov 3.

PMID:
29101246
21.

Congenital syphilis in England and amendments to the BASHH guideline for management of affected infants.

Kingston M, French P, Fifer H, Hughes G, Wilson J.

Int J STD AIDS. 2017 Nov;28(13):1361-1362. doi: 10.1177/0956462417733866. No abstract available.

PMID:
29027897
22.

Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services in England.

Pitt R, Fifer H, Woodford N, Alexander S.

Sex Transm Infect. 2018 Feb;94(1):9-13. doi: 10.1136/sextrans-2017-053164. Epub 2017 Jul 17.

PMID:
28717051
23.

Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study.

Turner KM, Christensen H, Adams EJ, McAdams D, Fifer H, McDonnell A, Woodford N.

BMJ Open. 2017 Jun 14;7(6):e015447. doi: 10.1136/bmjopen-2016-015447.

24.

First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.

Mohammed H, Sile B, Furegato M, Woodhall S, Fifer H, Hughes G.

BMJ. 2017 Feb 2;356:j565. doi: 10.1136/bmj.j565. No abstract available.

PMID:
28153820
25.

Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.

Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, Unemo M.

N Engl J Med. 2016 Jun 23;374(25):2504-6. doi: 10.1056/NEJMc1512757. No abstract available.

PMID:
27332921
26.

Poor adherence to gonorrhoea treatment guidelines in general practice in England.

Mohammed H, Sile B, Furegato M, Fifer H, Hughes G.

Br J Gen Pract. 2016 Jul;66(648):352. doi: 10.3399/bjgp16X686077. Epub 2016 Jun 20. No abstract available.

27.

Attitudes and Behaviours to Antimicrobial Prescribing following Introduction of a Smartphone App.

Panesar P, Jones A, Aldous A, Kranzer K, Halpin E, Fifer H, Macrae B, Curtis C, Pollara G.

PLoS One. 2016 Apr 25;11(4):e0154202. doi: 10.1371/journal.pone.0154202. eCollection 2016.

28.

The incidence of congenital syphilis in the United Kingdom: February 2010 to January 2015.

Simms I, Tookey PA, Goh BT, Lyall H, Evans B, Townsend CL, Fifer H, Ison C.

BJOG. 2017 Jan;124(1):72-77. doi: 10.1111/1471-0528.13950. Epub 2016 Mar 2.

29.

An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.

Chisholm SA, Wilson J, Alexander S, Tripodo F, Al-Shahib A, Schaefer U, Lythgow K, Fifer H.

Sex Transm Infect. 2016 Aug;92(5):365-7. doi: 10.1136/sextrans-2015-052312. Epub 2015 Nov 24.

PMID:
26601852
30.

British Association for Sexual Health and HIV: framework for guideline development and assessment.

Kingston M, Radcliffe K, Cousins D, Fifer H, FitzGerald M, Grover D, Hardman S, Higgins S, Rayment M, Sullivan A.

Int J STD AIDS. 2016 Mar;27(3):165-77. doi: 10.1177/0956462415610982. Epub 2015 Oct 12.

PMID:
26464503
31.

Gonorrhoea treatment position statement.

Fifer H, Hughes G, Radcliffe K.

Sex Transm Infect. 2015 Aug;91(5):307. doi: 10.1136/sextrans-2015-052220. No abstract available.

PMID:
26195472
32.

Nucleic acid amplification tests for the diagnosis of Neisseria gonorrhoeae in low-prevalence settings: a review of the evidence.

Fifer H, Ison CA.

Sex Transm Infect. 2014 Dec;90(8):577-9. doi: 10.1136/sextrans-2014-051588. Epub 2014 Jul 10. Review.

PMID:
25013081
33.

Invasive aspergillosis associated with pulmonary hydatid disease.

Fifer HM, Chiodini PL, Lucas SB, Brown JS.

Travel Med Infect Dis. 2012 Sep;10(5-6):272-4. doi: 10.1016/j.tmaid.2012.07.001. Epub 2012 Jul 21.

PMID:
22824534
34.

Chickenpox.

Breuer J, Fifer H.

BMJ Clin Evid. 2011 Apr 11;2011. pii: 0912. Review.

35.

Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.

Sutherland CJ, Fifer H, Pearce RJ, bin Reza F, Nicholas M, Haustein T, Njimgye-Tekumafor NE, Doherty JF, Gothard P, Polley SD, Chiodini PL.

Antimicrob Agents Chemother. 2009 Aug;53(8):3405-10. doi: 10.1128/AAC.00024-09. Epub 2009 May 11.

36.

The preparation of antifoam tablets.

DEAN SJ, FIFER HD.

Drug Stand. 1960 Jan-Feb;28:29-30. No abstract available.

PMID:
13815169

Supplemental Content

Support Center